We set out to reach the clinic in Q4, and we delivered. With our First In Human milestone achieved, Retro officially becomes a clinical stage company. Deep thanks to the teams who made this possible. We are excited for what 2026 will bring. https://lnkd.in/gi-R9H-3
Retro Biosciences
Biotechnology Research
We're Adding 10 Years to Healthy Human Lifespan
About us
Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to rejuvenate cell and tissue function with the ultimate aim of adding 10 years to healthy human lifespan.
- Website
-
http://retro.bio/
External link for Retro Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Redwood City
- Type
- Privately Held
Locations
-
Primary
Get directions
Redwood City, US
Employees at Retro Biosciences
Updates
-
We're excited to share a new blog post from OpenAI that highlights our collaboration using GPT-4b to accelerate protein engineering – including reengineering key transcription factors to improve stem cell generation. A powerful example of how our combined expertise in AI and longevity science can help make therapeutic breakthroughs. https://lnkd.in/g8HEjPMT
-
Our collaboration with OpenAI is featured today in an exclusive Endpoints article by Andy Dunn. The story covers how GPT-4b is helping us engineer proteins that drive stem cell reprogramming and move faster toward our mission. https://lnkd.in/gTgpSgNQ
-
“The MCRI and Retro both have a grand vision of turning the technology into preventative medicine, "Joe Betts-LaCroix" said. Replacing an aging blood system with a young one, based on a person’s own genetics, could help thwart blood-related diseases that people face later in life, creating a ‘significant age reset.’” Our thanks to Endpoints News reporter Kyle LaHucik for highlighting Retro’s new collaboration with Murdoch Children's Research Institute (MCRI). Learn more about our exclusive licensing agreement and Retro’s vision of adding 10 years of healthy lifespan 👇 https://lnkd.in/ggpnsWrA
-
We’re pleased to partner with Murdoch Children's Research Institute (MCRI) to advance personalized therapies for blood disorders of urgent need. Combining MCRI’s breakthrough in reprogramming blood stem cells and Retro’s expertise and advanced biotechnology is a step towards regenerative solutions that support a longer, healthier lifespan. Read the press release to learn more about the collaboration from our CEO "Joe Betts-LaCroix", MCRI professors Elizabeth Ng and Enzo Porrello, and Victorian Economic Growth and Jobs Minister Danny Pearson: https://lnkd.in/gHKFsp-Z